Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$161.01 - $317.85 $370,967 - $732,326
2,304 Added 677.65%
2,644 $836,000
Q3 2023

Nov 09, 2023

SELL
$164.66 - $218.08 $459,236 - $608,225
-2,789 Reduced 89.13%
340 $57,000
Q2 2023

Aug 09, 2023

BUY
$176.32 - $240.22 $471,832 - $642,828
2,676 Added 590.73%
3,129 $678,000
Q1 2023

May 12, 2023

SELL
$161.33 - $204.36 $207,793 - $263,215
-1,288 Reduced 73.98%
453 $82,000
Q4 2022

Feb 09, 2023

BUY
$191.53 - $236.82 $333,453 - $412,303
1,741 New
1,741 $342,000
Q2 2022

Aug 11, 2022

BUY
$93.97 - $143.33 $1.09 Million - $1.66 Million
11,584 Added 1081.61%
12,655 $1.6 Million
Q1 2022

May 12, 2022

SELL
$98.9 - $132.37 $681,717 - $912,426
-6,893 Reduced 86.55%
1,071 $136,000
Q4 2021

Feb 11, 2022

BUY
$110.64 - $159.4 $818,514 - $1.18 Million
7,398 Added 1307.07%
7,964 $1.04 Million
Q3 2021

Nov 12, 2021

SELL
$101.2 - $125.87 $563,380 - $700,718
-5,567 Reduced 90.77%
566 $69,000
Q2 2021

Aug 10, 2021

SELL
$107.45 - $135.95 $10,745 - $13,594
-100 Reduced 1.6%
6,133 $699,000
Q1 2021

May 12, 2021

BUY
$95.46 - $133.08 $305,090 - $425,323
3,196 Added 105.24%
6,233 $749,000
Q4 2020

Feb 10, 2021

BUY
$75.23 - $109.23 $228,473 - $331,731
3,037 New
3,037 $309,000
Q3 2020

Nov 12, 2020

SELL
$71.31 - $109.74 $50,558 - $77,805
-709 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$62.14 - $117.21 $8,264 - $15,588
133 Added 23.09%
709 $79,000
Q1 2020

May 13, 2020

BUY
$60.41 - $115.92 $34,796 - $66,769
576 New
576 $41,000

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.